Chemours turns to euros as it reprices $1.5bn term loan 'B'

Chemours, the listed US chemicals firm spun out of DuPont in 2015, held a lender call on Monday afternoon for a $350m-equivalent euro term loan to repay some of its existing dollar loan.

  • By Max Bower
  • 20 Mar 2017

The Wilmington, Delaware-based firm also wants to reprice its $1.5bn seven year term loan ‘B’, signed in 2015, after its $3bn spin-out from DuPont. The original margin was 300bp with a 0.75% Libor floor.

Price talk for the dollar repricing of 250bp with a 0% floor was released after ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 27 Mar 2017
1 Goldman Sachs 5,003.18 13 8.74%
2 Deutsche Bank 4,881.33 25 8.53%
3 JPMorgan 4,826.81 11 8.44%
4 Bank of America Merrill Lynch 4,337.47 13 7.58%
5 BNP Paribas 3,160.34 16 5.52%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 11 Apr 2017
1 Deutsche Bank 2,981.20 25 9.50%
2 Citi 2,705.59 14 8.62%
3 JPMorgan 2,305.05 18 7.35%
4 Bank of America Merrill Lynch 2,082.61 15 6.64%
5 Barclays 2,056.23 15 6.55%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 04 Apr 2017
1 JPMorgan 12,214.51 86 12.12%
2 Bank of America Merrill Lynch 9,891.30 80 9.81%
3 Citi 9,372.27 62 9.30%
4 Goldman Sachs 7,529.63 51 7.47%
5 Credit Suisse 6,129.63 44 6.08%